| Dr Henry F Pallatroni Iii, MD | |
|
330 Borthwick Ave, Suite 300, Portsmouth, NH 03801-4174 | |
| (603) 433-4666 | |
| (603) 433-1338 |
| Full Name | Dr Henry F Pallatroni Iii |
|---|---|
| Gender | Male |
| Speciality | Neurosurgery |
| Experience | 27 Years |
| Location | 330 Borthwick Ave, Portsmouth, New Hampshire |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003880238 | NPI | - | NPPES |
| 30205430 | Medicaid | NH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | 11788 (New Hampshire) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Amedisys Home Health | Portsmouth, NH | Home health agency |
| Portsmouth Regional Hospital | Portsmouth, NH | Hospital |
| Exeter Hospital Inc | Exeter, NH | Hospital |
| York Hospital | York, ME | Hospital |
| Huggins Hospital | Wolfeboro, NH | Hospital |
| Frisbie Memorial Hospital | Rochester, NH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Appledore Medical Group Inc | 5698666154 | 89 |
News Archive
A new study co-authored by investigators at the University of Massachusetts Medical School found that there is no correlation between opioids administered in the emergency room setting and Press Ganey ED patient satisfaction scores, one of the most commonly used metrics for measuring patient satisfaction.
"Critical limb ischemia" (CLI) describes an advanced stage of peripheral artery disease characterized by obstruction of the arteries and a markedly reduced blood flow to the extremities. CLI identifies patients at high-risk for major amputation. The estimated annual incidence of CLI ranges between 500 and 1000 new cases out of one million people per year, with the highest rates among the elderly, smokers, and those with diabetes. CLI is considered to be a critical public health issue. Attempts at revascularization are often unsuccessful.
Monday's "celebration of Earth Day is an opportunity to remind ourselves and our partners of the connection between our environment, agriculture, and food and nutrition security and how we can work together to end world hunger and undernutrition," Jonathan Shrier, acting special representative for global food security and deputy coordinator for diplomacy for Feed the Future, writes in the initiative's blog.
NeuroDerm, Ltd. announced today that enrollment of patients is ongoing in its second Phase II clinical trial of ND0612, a novel drug formulation for the treatment of Parkinson's disease. ND0612 is a proprietary levodopa/carbidopa liquid formulation under development for continuous subcutaneous administration through a patch pump. It is designed to provide steady levodopa blood levels for the treatment of Parkinson's disease.
Scientists from Graz, Austria, have now directly linked lipid metabolism and cancer-associated cachexia. Science reports via its online channel Science Express that mice deficient in the lipid degrading enzyme Adipose Triglyceride Lipase (ATGL) are fully protected against cancer-associated cachexia.
› Verified 7 days ago
| Entity Name | Appledore Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720077167 PECOS PAC ID: 5698666154 Enrollment ID: O20040601000165 |
News Archive
A new study co-authored by investigators at the University of Massachusetts Medical School found that there is no correlation between opioids administered in the emergency room setting and Press Ganey ED patient satisfaction scores, one of the most commonly used metrics for measuring patient satisfaction.
"Critical limb ischemia" (CLI) describes an advanced stage of peripheral artery disease characterized by obstruction of the arteries and a markedly reduced blood flow to the extremities. CLI identifies patients at high-risk for major amputation. The estimated annual incidence of CLI ranges between 500 and 1000 new cases out of one million people per year, with the highest rates among the elderly, smokers, and those with diabetes. CLI is considered to be a critical public health issue. Attempts at revascularization are often unsuccessful.
Monday's "celebration of Earth Day is an opportunity to remind ourselves and our partners of the connection between our environment, agriculture, and food and nutrition security and how we can work together to end world hunger and undernutrition," Jonathan Shrier, acting special representative for global food security and deputy coordinator for diplomacy for Feed the Future, writes in the initiative's blog.
NeuroDerm, Ltd. announced today that enrollment of patients is ongoing in its second Phase II clinical trial of ND0612, a novel drug formulation for the treatment of Parkinson's disease. ND0612 is a proprietary levodopa/carbidopa liquid formulation under development for continuous subcutaneous administration through a patch pump. It is designed to provide steady levodopa blood levels for the treatment of Parkinson's disease.
Scientists from Graz, Austria, have now directly linked lipid metabolism and cancer-associated cachexia. Science reports via its online channel Science Express that mice deficient in the lipid degrading enzyme Adipose Triglyceride Lipase (ATGL) are fully protected against cancer-associated cachexia.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Henry F Pallatroni Iii, MD Psc 482 Box 169, Fpo, AP 96362-0002 Ph: (611) 743-7210 | Dr Henry F Pallatroni Iii, MD 330 Borthwick Ave, Suite 300, Portsmouth, NH 03801-4174 Ph: (603) 433-4666 |
News Archive
A new study co-authored by investigators at the University of Massachusetts Medical School found that there is no correlation between opioids administered in the emergency room setting and Press Ganey ED patient satisfaction scores, one of the most commonly used metrics for measuring patient satisfaction.
"Critical limb ischemia" (CLI) describes an advanced stage of peripheral artery disease characterized by obstruction of the arteries and a markedly reduced blood flow to the extremities. CLI identifies patients at high-risk for major amputation. The estimated annual incidence of CLI ranges between 500 and 1000 new cases out of one million people per year, with the highest rates among the elderly, smokers, and those with diabetes. CLI is considered to be a critical public health issue. Attempts at revascularization are often unsuccessful.
Monday's "celebration of Earth Day is an opportunity to remind ourselves and our partners of the connection between our environment, agriculture, and food and nutrition security and how we can work together to end world hunger and undernutrition," Jonathan Shrier, acting special representative for global food security and deputy coordinator for diplomacy for Feed the Future, writes in the initiative's blog.
NeuroDerm, Ltd. announced today that enrollment of patients is ongoing in its second Phase II clinical trial of ND0612, a novel drug formulation for the treatment of Parkinson's disease. ND0612 is a proprietary levodopa/carbidopa liquid formulation under development for continuous subcutaneous administration through a patch pump. It is designed to provide steady levodopa blood levels for the treatment of Parkinson's disease.
Scientists from Graz, Austria, have now directly linked lipid metabolism and cancer-associated cachexia. Science reports via its online channel Science Express that mice deficient in the lipid degrading enzyme Adipose Triglyceride Lipase (ATGL) are fully protected against cancer-associated cachexia.
› Verified 7 days ago
Gareth Davies, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 330 Borthwick Ave, Suite 300, Portsmouth, NH 03801 Phone: 603-433-4666 Fax: 603-433-1338 |